Please assess the completion status of the following clinical trial:

Trial Title: Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~° Consecutive adult patients over 18 years of age scheduled to undergo VATS because of verified/suspected lung cancer.~Exclusion Criteria:~* Inability to understand verbal and written information.~* Preexisting chronic pain condition.~* Preoperative daily treatment with pain medication (Non-opioids, opioids, gabapentin/pregabalin).~* Previous thoracic surgery.~* Previous chemotherapy due to thoracic malignancy and / or radiation therapy. to the thorax.~* Pregnant women.~* Autoimmune neuromuscular diseases (sclerosis, peripheral neuromuscular disorders). General muscle weakness or atrophy.~* Hypersensitivity, allergy or intolerance to dexamethasone, bupivacaine or adrenaline.~* Preoperative epidural anaesthesia.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Before implementation (Type: None): Perineural bupivacaine without adjuvants.
- After implementation (Type: None): Perineural bupivacaine with intravenous dexamethasone.

Based on this trial design, predict the completion outcome and termination type (if applicable).